The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor.
BACKGROUND
Large DNA-viruses such as herpesvirus and poxvirus encode proteins that target and exploit the chemokine system of their host. The Kaposi sarcoma- associated herpes virus (KSHV) encodes three chemokines. Two of these, vCCL2 and vCCL3, target the human lymphotactin receptor as an antagonist and a selective agonist, respectively. Therefore these virally endcoded chemokines have the potential to be used as tools in the study of lymphotactin receptor pathways in murine models.


RESULTS
The activities of vCCL2, vCCL3, human lymphotactin (XCL1) and murine lymphotactin (mXCL1) were probed in parallel on the human and murine lymphotactin receptor (XCR1 and mXCR1) using a phosphatidyl-inositol assay. On the human XCR1, vCCL3, mXCL1 and XCL1 acted as agonists. In contrast, only mXCL1 was able to activate the murine lymphotactin receptor. Using the same assay, vCCL2 was able to block the response using any of the three agonists on the humane lymphotactin receptor with IC50s of 2-3 nM. However, vCCL2 was unable to block the response of mXCL1 through the murine lymphotactin receptor.


CONCLUSIONS
This study shows that vCCL2 and vCCL3 cannot be used to investigate lymphotactin receptor pathways in murine models. These results also add vCCL2 and vCCL3 to a growing list of viral chemokines with known human chemokine receptor targets, which do not target the corresponding murine receptors. This fits with the observation that viral and endogenous ligands for the same human chemokine receptor tend to have relatively divergent amino-acid sequences, suggesting that these viruses have fine-tuned the design of their chemokines such that the action of the viral encoded chemokines cannot be expected to cross species barriers.
Lüttichau
Hans R
HR
Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Panum Institute, DK-2200 Copenhagen, Denmark. LUTTICHAU@sund.ku.dk
D000595:Amino Acid Sequence; D000818:Animals; D018925:Chemokines / Q000378:metabolism*; D019744:Chemokines, C / Q000378:metabolism; D016000:Cluster Analysis; D019288:Herpesvirus 8, Human / Q000502:physiology*; D006801:Humans; D020128:Inhibitory Concentration 50; D051379:Mice; D008969:Molecular Sequence Data; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D014764:Viral Proteins / Q000378:metabolism*
D018925:Chemokines; D019744:Chemokines, C; D043562:Receptors, G-Protein-Coupled; D014764:Viral Proteins; C092390:XCL1 protein, human; C091671:XCR1 protein, human; C486249:Xcl1 protein, mouse; C108059:vMIP-II; C404961:vMIP-III protein, Herpesvirus 8, Human